Unknown

Dataset Information

0

Regulatory polymorphisms in ?-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.


ABSTRACT: Peripheral neuropathy is the dose-limiting toxicity of paclitaxel, a chemotherapeutic drug widely used to treat several solid tumors such as breast, lung, and ovary. The cytotoxic effect of paclitaxel is mediated through ?-tubulin binding in the cellular microtubules. In this study, we investigated the association between paclitaxel neurotoxicity risk and regulatory genetic variants in ?-tubulin genes.We measured variation in gene expression of three ?-tubulin isotypes (I, IVb, and IIa) in lymphocytes from 100 healthy volunteers, sequenced the promoter region to identify polymorphisms putatively influencing gene expression and assessed the transcription rate of the identified variants using luciferase assays. To determine whether the identified regulatory polymorphisms were associated with paclitaxel neurotoxicity, we genotyped them in 214 patients treated with paclitaxel. In addition, paclitaxel-induced cytotoxicity in lymphoblastoid cell lines was compared with ?-tubulin expression as measured by Affymetrix exon array.We found a 63-fold variation in ?-tubulin IIa gene (TUBB2A) mRNA content and three polymorphisms located at -101, -112, and -157 in TUBB2A promoter correlated with increased mRNA levels. The -101 and -112 variants, in total linkage disequilibrium, conferred TUBB2A increased transcription rate. Furthermore, these variants protected from paclitaxel-induced peripheral neuropathy [HR, 0.62; 95% confidence interval (CI), 0.42-0.93; P = 0.021, multivariable analysis]. In addition, an inverse correlation between TUBB2A and paclitaxel-induced apoptosis (P = 0.001) in lymphoblastoid cell lines further supported that higher TUBB2A gene expression conferred lower paclitaxel sensitivity.This is the first study showing that paclitaxel neuropathy risk is influenced by polymorphisms regulating the expression of a ?-tubulin gene.

SUBMITTER: Leandro-Garcia LJ 

PROVIDER: S-EPMC3664665 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.

Leandro-García Luis J LJ   Leskelä Susanna S   Jara Carlos C   Gréen Henrik H   Avall-Lundqvist Elisabeth E   Wheeler Heather E HE   Dolan M Eileen ME   Inglada-Perez Lucia L   Inglada-Perez Lucia L   Maliszewska Agnieszka A   de Cubas Aguirre A AA   Comino-Méndez Iñaki I   Mancikova Veronika V   Cascón Alberto A   Robledo Mercedes M   Rodríguez-Antona Cristina C  

Clinical cancer research : an official journal of the American Association for Cancer Research 20120620 16


<h4>Purpose</h4>Peripheral neuropathy is the dose-limiting toxicity of paclitaxel, a chemotherapeutic drug widely used to treat several solid tumors such as breast, lung, and ovary. The cytotoxic effect of paclitaxel is mediated through β-tubulin binding in the cellular microtubules. In this study, we investigated the association between paclitaxel neurotoxicity risk and regulatory genetic variants in β-tubulin genes.<h4>Experimental design</h4>We measured variation in gene expression of three β  ...[more]

Similar Datasets

| S-EPMC4592389 | biostudies-literature
| S-EPMC3475250 | biostudies-literature
| S-EPMC6289693 | biostudies-literature
| S-EPMC7945004 | biostudies-literature
| S-EPMC7848563 | biostudies-literature
| S-EPMC5368986 | biostudies-literature
| S-EPMC5988965 | biostudies-literature
| S-EPMC6173931 | biostudies-literature